Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Leukemia

Free Subscription Articles published in Cancer Chemother Pharmacol Retrieve available abstracts of 20 articles: HTML format

Single Articles

April 2008
1. THOMADAKI H , Tsiapalis CM, Scorilas A
   The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines.
   Cancer Chemother Pharmacol. 2008;61:703-11.
   PubMed     Related articles    Abstract available
   
   
   
2. DUECHLER M , Stanczyk M, Czyz M, Stepnik M, et al
   Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
   Cancer Chemother Pharmacol. 2008;61:727-37.
   PubMed     Related articles    Abstract available
   
   
   February 2008
3. THOMADAKI H , Scorilas A, Tsiapalis CM, Havredaki M, et al
   The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner.
   Cancer Chemother Pharmacol. 2008;61:251-65.
   PubMed     Related articles    Abstract available
   
   
   December 2007
4. GENTILE M , Lucia E, Iorio C, Vigna E, et al
   Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
   Cancer Chemother Pharmacol. 2007;.
   PubMed     Related articles    Abstract available
   
   
   October 2007
5. MOLLGARD L , Deneberg S, Nahi H, Bengtzen S, et al
   The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemia.
   Cancer Chemother Pharmacol. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
6. FIEGL M , Lindner LH, Juergens M, Eibl H, et al
   Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs.
   Cancer Chemother Pharmacol. 2007;.
   PubMed     Related articles    Abstract available
   
   
   September 2007
7. COLE PD , Drachtman RA, Masterson M, Smith AK, et al
   Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia.
   Cancer Chemother Pharmacol. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
8. LINDHAGEN E , Nissle S, Leoni L, Elliott G, et al
   R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells.
   Cancer Chemother Pharmacol. 2007;60:545-53.
   PubMed     Related articles    Abstract available
   
   
   August 2007
9. IZZEDINE H , Buhaescu I, Rixe O, Deray G, et al
   Sunitinib malate.
   Cancer Chemother Pharmacol. 2007;60:357-64.
   PubMed     Related articles    Abstract available
   
   
   June 2007
10. CASHEN AF , Shah AK, Todt L, Fisher N, et al
    Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
11. VIGNA E , Lucia E, Gentile M, Mazzone C, et al
    PDGFRalpha/FIP1L1-positive chronic eosinophilic leukemia presenting with retro-orbital localization: efficacy of imatinib treatment.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
12. ZHENG LM , Li Z, Liu L, Song BL, et al
    Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
    Cancer Chemother Pharmacol. 2007;60:45-51.
    PubMed     Related articles    Abstract available
    
    
    April 2007
13. ZHANG K , Xu J, Huang X, Wu L, et al
    Trichosanthin down-regulated p210(Bcr-Abl) and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
14. TEDESCHI A , Montillo M, Strocchi E, Cafro AM, et al
    High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    December 2006
15. PIARD C , Bressolle F, Fakhoury M, Zhang D, et al
    A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
16. KOEHL U , Hollatz G, Rohrbach E, Visschedyk K, et al
    Pharmacology of intracellular cytosine-arabinoside-5'-triphosphate in malignant cells of pediatric patients with initial or relapsed leukemia and in normal lymphocytes.
    Cancer Chemother Pharmacol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
17. THOMPSON PA , Murry DJ, Rosner GL, Lunagomez S, et al
    Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
18. MINDERMAN H , Zhou Y, O'loughlin KL, Baer MR, et al
    Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status.
    Cancer Chemother Pharmacol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
19. SHAH NP
    Improving upon the promise of targeted therapy of human malignancy: chronic myeloid leukemia as a paradigm.
    Cancer Chemother Pharmacol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
20. FALTAOS DW , Hulot JS, Urien S, Morel V, et al
    Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.
    Cancer Chemother Pharmacol. 2006;58:626-33.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: